Abstract The human cathelicidin LL-37 has broad-spectrum antimicrobial activity. It also participates at the interface of innate and adaptive immunity by chemoattracting immune effector cells, modulating the production of a variety of inflammatory mediators by different cell types, and regulating the differentiation of monocytes into dendritic cells. In this study, we investigated the effects of LL-37 on the differentiation of human monocytes into anti-inflammatory macrophages (Mφ-2; driven by M-CSF) versus proinflammatory macrophages (Mφ-1; driven by GM-CSF) as well as on fully differentiated Mφ-1 and Mφ-2. Results revealed that monocytes cultured with M-CSF in the presence of LL-37 resulted in macrophages displaying a proinflammatory signature, namely, low expression of CD163 and little IL-10 and profound IL-12p40 production on LPS stimulation. The effects of LL-37 on M-CSF-driven macrophage differentiation were dose-and time-dependent with maximal effects observed at 10 mg/ml when the peptide was present from the start of the cultures. The peptide enhanced the GM-CSF-driven macrophage differentiation. Exposure of fully differentiated Mφ-2 to LL-37 for 6 d resulted in macrophages that produced less IL-10 and more IL12p40 on LPS stimulation than control Mφ-2. In contrast, LL-37 had no effect on fully differentiated Mφ-1. Peptide mapping using a set of 16 overlapping 22-mer peptides covering the complete LL-37 sequence revealed that the C-terminal portion of LL-37 is responsible for directing macrophage differentiation. Our results furthermore indicate that the effects of LL-37 on macrophage differentiation required internalization of the peptide. Together, we conclude that LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature.
Introduction
Macrophages (and dendritic cells [DCs] ) in tissues continuously monitor their microenvironment for invading pathogens and other danger signals. On pathogen encounter, they trigger the migration of neutrophils and monocytes into the affected site and regulate an adequate innate immune response. In this regulatory process, macrophages may serve a dual purpose. Initially, they contribute to the elimination of pathogens and the elicitation of an inflammatory reaction. When the infection recedes due to removal of pathogens and cell debris, however, their function may shift toward resolution of inflammation and tissue repair (1) . Macrophages can thus exhibit pro and anti-inflammatory properties to a degree that is determined by stimuli from their local microenvironment, such as pathogens, inflammatory mediators as well as other factors. In line with this notion, two clearly distinct types of human macrophages, designated as Mφ-1, namely, macrophages with a proinflammatory signature, and Mφ-2, which are macrophages having an anti-inflammatory/proangiogenic signature, have been derived from cultured human blood monocytes by incubation with GM-CSF and M-CSF, respectively (2) . Mφ-1s are fried egg-shaped macrophages that profoundly produce IL12p40 and little IL-10 on stimulation by LPS and support Th cell type 1 (Th1) responses.
Mφ-2 display a stretched, spindle-like morphology and are characterized by the marked production of IL-10 and little IL-12p40 on LPS stimulation (2), poor Ag-presenting capacities, and promotion of T regulatory cell responses (3) . A hallmark of Mφ-2 is the cellsurface expression of CD163, the scavenger receptor involved in the clearance of free hemoglobin from the circulation (4) and supposedly functionally associated with antiinflammatory processes (5) . Cationic antimicrobial peptides, such as cathelicidins (6) , play important roles in the defense against infections by eliminating a wide range of pathogens (7, 8) . hCAP-18/LL-37 is the only cathelicidin identified in humans and it is produced by neutrophils, monocytes, mast cells, and epithelial cells. It is stored in these cells as a propeptide, which can be cleaved extracellular by enzymes like proteinase 3, resulting in the formation of LL-37 and a cathelin part. LL-37 is an amphipathic α-helical peptide that can affect both planktonic bacteria and those residing in biofilms (9, 10) , viruses such as HIV (11) and fungi (12) , and it can neutralize LPS and lipoteichoic acid (LTA) (13) . In addition to its antimicrobial actions, LL-37 participates at the interface of innate and adaptive immunity by modulating cytokine and chemokine production by a range of cell types, chemoattracting various immune effector cells (14) and mesenchymal stem cells (15) , regulating autophagy in conjunction with vitamin D (16) , and stimulating angiogenesis and wound healing (17) . Others reported that LL-37 enhances the GM-C h a p t e r 4 | 65 CSF/IL-4-driven differentiation of blood monocytes to immature DCs (18) , whereas inhibiting the maturation of immature DCs by TLR ligands (19) . Furthermore, this peptide enhances the responses of monocytes (and macrophages) to GM-CSF and IL-1β (20, 21) , but suppresses those to IFN-γ (22) , indicating that LL-37 affects the responses of mononuclear phagocytes to cytokines differentially. All effects of LL-37 on human cells may be mediated through specific cell-surface receptors (14, (23) (24) (25) (26) or intracellular receptors (27) . The effects of LL-37 on macrophage differentiation are not known. As LL-37
can be abundantly present at sites of inflammation/infection (28) (29) (30) and monocytemacrophage differentiation depends on factors from the local microenvironment, in this study, we investigated the effects of LL-37 on the differentiation of monocytes to pro and anti-inflammatory macrophages.
Materials and Methods
LL-37 and derived peptides Human LL-37, control scrambled peptide (LG-37), as well as the set of 16 overlapping 22mer peptides covering the complete amino acid sequence of LL-37 were prepared by solid phase synthesis on an automated peptide synthesizer (SyroII, Multisyntech, Witten, Germany) as described (31) . The sequences of the various peptides are summarized in Table I . The purity of the various peptides was at least 87%, as determined by reverse-phase high performance chromatography, and their molecular mass was confirmed by Maldi-Tof mass spectrometry. Stocks (50 mg/ml) of the peptides prepared in DMSO were kept at -80°C until use.
Isolation of human monocytes PBMCs from healthy donors were isolated from buffy coats (Sanquin Blood Bank, Leiden, The Netherlands) by Ficoll Amidotrizoate (ρ = 1.077 g/ml; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands) density centrifugation at 700 x g for 20 min. Cells in the interphase were washed three times with PBS (pH 7.4), and monocytes were isolated using antiCD14-coated MACS microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) according to manufacturer's instructions. Next, monocytes (puritiy >96%, viability >98% as determined by annexin V and PI staining 2 h after isolation) were centrifuged and resuspended in RPMI 1640 supplemented with 2 mM glutamine, 2 mM penicillin and streptomycin, and 10% (weight/volume) heat-inactivated FCS (all from Life Technologies, Invitrogen, Breda, The Netherlands), further referred to as standard medium. 
Involvement of intracellular uptake of LL-37 in its effects on macrophage differentiation
To investigate whether LL-37 needs to be taken up by monocytes for its effects on the M-CSF-driven macrophage differentiation, monocytes were preincubated for 30 min with 5 μg/ml cytochalasin-D (Sigma-Aldrich, stock 5 mg/ml DMSO). Next, the cells were washed to remove unbound cytochalasin-D and thereafter the cells were incubated for 6-7 d in M-CSF-containing medium supplemented with 10 μg/ml LL-37 or not.
Statistical analysis Statistical analyses were performed by Wilcoxon's matched pairs test
or Friedman repeated measures test, as appropriate, to determine the difference between groups using GraphPad Prism 4.0 (San Diego, CA) software. Differences were considered significant when p < 0.05.
Results
Effects of LL-37 on the differentiation of monocytes to Mφ-1 and Mφ-2 To determine the effects of LL-37 on the differentiation of monocytes to Mφ-2 or Mφ-1, we incubated monocytes for 6 d with M-CSF or GM-CSF in the presence of either LL-37, the scrambled peptide LG-37 (Table I) 1A ). In line with this, the presence of LL-37 during M-CSF-driven macrophage differentiation led to macrophages expressing significantly less CD163 and CD14 than control macrophages did (Fig. 1B) . Furthermore, macrophages differentiated by M-CSF in the presence of LL-37 produced significantly less IL-10 and more IL-12p40 on LPS stimulation than macrophages differentiated by M-CSF in the presence of LG-37 (results not shown) or no peptide (Fig. 2A) ; without LPS stimulation no effect of LL-37 on the production of these cytokines was seen (Table II) . These effects were already observed with 5 μg/ml LL-37 and maximal at ≥10 mg/ml LL-37 ( Cytokine production by LL-37-differentiated macrophages in response to various bacterial stimuli To determine whether the modulatory effect of LL-37 on the M-CSFdriven macrophage differentiation with respect to the cytokine profile was restricted to LPS/TLR4, we used other bacterial stimuli, such as M. tuberculosis, LTA, PAM3, and ZymA. The results revealed that exposure of macrophages differentiated by M-CSF in the presence of LL-37 to these stimuli resulted in macrophages displaying significantly decreased IL-10 production (M. tuberculosis lysate and LPS [i.e., stimuli signaling through TLR4 and TLR2] but not the stimuli signaling through TLR2, TLR2/1, and TLR2/6) and more IL-12p40 production than macrophages differentiated by M-CSF alone (Table II) .
Interestingly, LL-37 did not influence the GM-CSF-driven macrophage differentiation as judged by cell morphology (Fig. 1A) and expression of CD163 and CD14 (results not shown)
by the resulting macrophages. However, these LL-37-exposed macrophages produced significantly less IL-10, and more IL-12p40, on stimulation with the various stimuli than control macrophages did ( Fig. 2A , Table II ).
C h a p t e r 4 | 71 ◄Fig. 2 Effects of LL-37 on the M-CSF-driven and GM-CSF-driven monocyte-macrophage differentiation regarding LPS-stimulated IL-10 and IL-12p40 production Monocytes were cultured for 6 d in medium containing M-CSF (to generate Mφ-2) or GM-CSF (to generate Mφ-1) in the presence of LL-37 (gray boxes) or no peptide (white boxes). At day 6, these cultures were stimulated for 24 h with 100 ng/ml LPS and the levels for IL-10 and IL-12p40 in the culture supernatants were measured by ELISA (A). Box plots display the median, the second and third interquartiles, and the lowest and highest cytokine concentrations. n = 5 independent experiments. *p < 0.05. Monocytes were cultured for 6 d with M-CSF together-for the indicated intervals-with LL-37. At day 6, macrophages were washed and then stimulated with LPS for 24 h. Thereafter, levels of IL-10 and IL-12p40 in the culture supernatants were measured by ELISA (B). Box plots display the median, the second and third interquartile, and the lowest and highest cytokine concentrations. n = 5 independent experiments. *p < 0.05. Monocytes were cultured for 6 d in medium containing M-CSF or GM-CSF in the presence of 10 μg/ml LL-37 or no peptide (none). At day 6, the cells were incubated with medium supplemented with 5 μg/ml M. tuberculosis lysate, 1 μg/ml LTA, 100 ng/ml PAM3, 10 μg/ml ZymA, 100 ng/ml LPS, or no stimulus (none) for 24 h. The concentrations of the indicated cytokines in the supernatants were quantified by ELISA. Values are medians and range. n = number of different donors. *p < 0.05, compared with similar macrophages not incubated with LL-37 but exposed to the same stimulus.
LL-37 modulates fully differentiated Mφ-2
To investigate the ability of LL-37 to redirect fully differentiated macrophages we added this peptide (10 μg/ml) or scrambled peptide
LG-37 to fully differentiated Mφ-2 and Mφ-1 and maintained the cells for an additional 6 d in culture medium. At the end of this second culture period, macrophages were washed and then stimulated for 24 h with LPS. Results revealed that culturing of fully differentiated Mφ-2 with LL-37 for 6 d resulted in macrophages that produced significantly less IL-10 and more IL-12p40 on LPS stimulation than Mφ-2 cultured with scrambled peptide or no peptide (Fig. 3) . In contrast, culturing of fully differentiated Mφ-1 with LL-37
did not affect IL-10 and IL-12p40 production by the resulting macrophages in response to LPS (Fig. 3) . Fig. 3 Effects of LL-37 on fully differentiated macrophages Fully differentiated Mφ-2 and Mφ-1 were cultured for an additional 6 d in medium supplemented with LL-37 (10 μg/ml; gray boxes), LG-37 (10 μg/ml; hatched boxes), or no peptide (white boxes) and then stimulated with LPS (100 ng/ml) for 24 h. Thereafter, the levels of the indicated cytokines in the culture supernatants were assessed by ELISA. Box plots display the median, the second and third interquartile, and the lowest and highest cytokine concentrations. n = 7-8 independent experiments. *p < 0.05. M-CSF led to low/undetectable expression levels of CD163 (Fig. 4A ). In line with this observation, macrophages differentiated in the presence of these peptides produced significantly more IL-12p40 on LPS than Mφ-2 did (Fig. 4B) . Analyses of the dose-effect relations for these C-terminal peptides indicated that peptides 11 and 12 were the most effective peptides in modulating M-CSF-driven macrophage differentiation (results not shown). 
Effects of LL-37-derived peptides on the M-CSF-driven macrophage differentiation

LL-37 does not affect monocyte viability Monocytes were cultured in medium containing
M-CSF supplemented with LL-37 (or LG-37 or no peptide) for 24 h and thereafter stained with annexin V-FITC and PI. Subsequent FACS analysis revealed that the viability of monocytes amounted to 61 ± 3% (n = 3) and that of monocytes treated with LL-37 to 72 ± 4% (n = 3) and monocytes exposed to LG-37 to 65 ± 4% (n = 3), indicating that LL-37 at the present concentrations is not toxic for monocytes. In addition, no effect of LL-37 on the viability of monocytes exposed to 10 ng GM-CSF/ml and 50 ng M-CSF/ml was observed (results not shown).
Discussion
The main conclusion from the current study is that LL-37 directs M-CSF-driven monocytemacrophage differentiation toward macrophages with a proinflammatory signature and redirects fully differentiated Mφ-2. In agreement with reports by others that LL-37 can enhance the effects of GM-CSF (18, 21), we found LL-37 to enforce the GM-CSF-driven macrophage differentiation. Our conclusion is based on the following findings. First, addition of LL-37 to 6 d cultures of monocytes with M-CSF resulted in macrophages with a proinflammatory instead of an anti-inflammatory signature. Our observation that LL-37
added at the start of the monocyte cultures is more effective than when added on the second or subsequent days may indicate that LL-37 either affects monocytes more effectively than macrophages or it exerts its modulatory effects only when continuously present. The actions of LL-37 on macrophage differentiation regarding the cytokine profile were independent of the stimulus used for inducing cytokine production. This was found for all stimuli used, except ZymA and PAM 3 , which may be explained by the poor response of the macrophages to these two stimuli using IL-10 and IL-12p40 as read-outs.
Furthermore, it should be noted that the effects of LL-37 on M-CSF-driven macrophage differentiation (and fully differentiated Mφ-2) are sequence-specific as the scrambled peptide LG-37 was without effect. Secondly, culturing of fully differentiated Mφ-2 for 6 d
with LL-37 resulted in macrophages producing more IL-12p40 and less IL-10 on LPS stimulation than control Mφ-2 did. In agreement, LL-37 promoted the development of macrophages with a fried egg-shaped appearance from fully differentiated Mφ-2, although the peptide did not affect the CD163 expression by these macrophages. It should be realized that the doses of LL-37 used in our study (1-20 μg/ml) are within the physiological range, namely, levels of LL-37 at sites of infection, such as tracheal aspirates of newborn infants, with an airway infection [LL-37 levels ranging between 5 and 15 μg/ml; (28)] and psoriasis skin lesions [up to 1.5 mg of LL-37/ml; (29) ]. The second conclusion to be drawn from our findings is that the C-terminal part of LL-37 harbors its ability to modulate M-CSF-driven macrophage differentiation, because of all tested LL-37-derived peptides only those comprising the C-terminal part were effective. Dose response experiments revealed that the peptides covering residues 11-32 and 12-33 were the most effective in modulating macrophage differentiation. Secondary structure prediction (33) indicated that these peptides comprise the optimal amphipathic helix among the present LL-37-derived peptides examined in this study. Preliminary experiments revealed that these C-terminal peptides are more effective than LL-37 in killing of and control monocytes did not differ. In addition, we noted that cytochalasin-D pretreated and control monocytes differentiated to type-2 macrophages equally well, for example, these macrophages express equal levels of CD163 and IL-12p40 production on LPS stimulation. The intracellular target of LL-37 in human monocytes could be GAPDH, which was recently shown to be also essential for the LL-37-induced activation of p38 MAPK C h a p t e r 4 | 77 signaling in monocytes (27) . Others reported that the LL-37-induced activation of p38 MAPK signaling in monocytes is enhanced in the presence of GM-CSF, but not M-CSF (21).
Furthermore, LL-37 internalized by DCs was found to be responsible for the altered morphological and functional characteristics of these cells (37) . Finally, in view of the observed effects of LL-37 alone or in synergy with other mediators on cytokine and chemokine secretion of monocytes and macrophages (13, 20, 21) , it cannot be excluded that LL-37 directs macrophage differentiation via its effects on cytokine actions/production. What could be the relevance of the current findings? M-CSF is constitutively produced by a variety of cells and circulates at detectable levels under steady-state conditions in serum and extracellular space (1) . Most macrophage populations in the tissues are exposed to levels of tissue-derived M-CSF (38, 39) (19) . In addition, it can enhance plasmacytoid DCs to produce IFN-α in response to self-DNA (41) .When the infection recedes due to removal of pathogens and cellular debris by phagocytes, the levels of LL-37/GM-CSF in the local environment subside to homeostatic levels that facilitate differentiation of monocytes to macrophages with the "default" anti-inflammatory signature again. These cells suppress the inflammatory responses (42, 43) and induce regulatory T cells (3) and mediate tissue repair (44) . Taken together, we demonstrated that LL-37 can (re)direct macrophage differentiation toward macrophages with a proinflammatory profile. These macrophages play important roles in the clearance of infections and tissue homeostasis.
